Piper Jaffray Downgrades Human Genome Sciences (HGSI) to Neutral; Albuferon SVR Rate Inferior to Pegasys
Tweet Send to a Friend
Piper Jaffray & Co. downgrades Human Genome Sciences (Nasdaq: HGSI) from Buy to Neutral. Price target lowered from $6 to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
